Understand what your iron blood health results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
DIC and the blood signature of a coagulation crisis
DIC biomarkers are blood measurements that translate the body’s hidden clotting crisis into clear signals. In disseminated intravascular coagulation, the blood forms countless tiny clots while exhausting its ability to clot where it’s needed. Testing captures three linked processes. Clot formation is shown by markers of active thrombin and new fibrin (prothrombin fragment 1+2, thrombin–antithrombin complexes, soluble fibrin). Consumption appears as dwindling clotting building blocks and cells (fibrinogen, platelets) and slower clotting on timing tests (prolonged PT and aPTT). Breakdown is revealed by excess fragments from dissolved fibrin (D‑dimer, fibrin degradation products). Natural brakes on clotting are also depleted (antithrombin, protein C). Read together, this pattern maps the simultaneous overdrive and burnout of the coagulation and fibrinolytic systems—a biological fingerprint of DIC. Tracking these biomarkers helps may support clinical assessment of the diagnosis, gauge how extensive and dynamic the process is, point to underlying triggers, and guide urgent treatment decisions over time.
Why tracking DIC markers is time-critical
Blood testing for disseminated intravascular coagulation (DIC) matters because it reveals a whole‑body collision between clotting and inflammation. In DIC, the coagulation system is overactivated, forming microclots that starve organs of oxygen while simultaneously consuming platelets and fibrinogen so bleeding ensues. Lab markers map this cascade in real time and help distinguish DIC from other causes of bleeding or clotting. Typical ranges: Platelets 150–450, WBC 4–10, and CRP is usually very low in health, often under 3. In DIC, platelets trend down, clotting times (PT/INR and aPTT) prolong, fibrinogen falls, and D‑dimer rises sharply. WBC and CRP often increase when DIC is triggered by sepsis, the most common driver. Optimal values in stable health tend to sit near the middle of the platelet and WBC ranges and at the low end for CRP.When values are low, they signal consumption: falling platelets and fibrinogen reflect ongoing thrombin generation and fibrinolysis, yielding easy bruising, petechiae, gum bleeding, oozing from lines, and postpartum or surgical hemorrhage. Microvascular clots can simultaneously cause confusion, breathlessness, chest or limb pain, and reduced urine from organ ischemia. In pregnancy, a rapid drop in platelets and fibrinogen with rising D‑dimer and PT suggests obstetric DIC; newborns have lower fibrinogen reserves and decompensate faster. Low WBC, though less typical, may indicate marrow suppression or overwhelming infection and portends worse outcomes. Big picture: DIC testing integrates hemostasis, immune signaling, and endothelial health. Tracking platelets, CRP/WBC, fibrinogen, PT/aPTT, and D‑dimer links the trigger (infection, trauma, cancer, obstetric complications) to organ risk, helping gauge severity and prognosis and aligning care with the underlying systemic physiology.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
What DIC testing can and can't resolve
Disseminated Intravascular Coagulation (DIC) is a complex condition where the body’s clotting system becomes overactive, leading to both excessive clotting and bleeding. This process can disrupt blood flow, affecting energy delivery, organ function, and immune defense. At Superpower, we assess DIC risk and activity by measuring three key blood biomarkers: Platelets, White Blood Cells (WBC), and C-Reactive Protein (CRP).Platelets are small cell fragments essential for blood clotting. In DIC, platelets are rapidly consumed as clots form throughout the body, often leading to a low platelet count (thrombocytopenia). White blood cells are part of the immune system and can increase in response to inflammation or infection, both of which can trigger or worsen DIC. C-Reactive protein is a marker of systemic inflammation; elevated CRP levels signal that the body is under stress, which can be a driving factor in DIC.Healthy levels of platelets help maintain stable clotting, preventing both unwanted bleeding and excessive clot formation. Balanced WBC counts reflect a well-regulated immune response, while normal CRP levels indicate low systemic inflammation. Together, these markers provide a snapshot of the body’s ability to maintain vascular stability and respond to stressors without tipping into dangerous clotting or bleeding. Interpretation of these biomarkers can be influenced by factors such as recent infections, pregnancy, age, chronic illnesses, or certain medications. Laboratory methods and reference ranges may also vary, so results are helps assess understood in the context of the individual’s overall health and clinical picture.
Frequently Asked Questions
References
- Levi M, Ten Cate H (1999). Disseminated intravascular coagulation. *The New England Journal of Medicine*, *341*(8), 586-592. https://doi.org/10.1056/NEJM199908193410807
- Gando S, Levi M, Toh CH (2016). Disseminated intravascular coagulation. *Nature Reviews Disease Primers*, *2*, 16037. https://doi.org/10.1038/nrdp.2016.37
- Taylor FB, Jr., Toh CH, Hoots WK, Wada H, Levi M (2001). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. *Thrombosis and Haemostasis*, *86*(5), 1327-1330. https://pubmed.ncbi.nlm.nih.gov/11816725/
- Carr JM, McKinney M, McDonagh J (1989). Diagnosis of disseminated intravascular coagulation. Role of D-dimer. *American Journal of Clinical Pathology*, *91*(3), 280-287. https://doi.org/10.1093/ajcp/91.3.280
- Wada H, Thachil J, Di Nisio M, Mathew P, Kurosawa S, Gando S, Kim HK, Nielsen JD, Dempfle CE, Levi M, Toh CH (2013). Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. *Journal of Thrombosis and Haemostasis*, *11*(4), 761-767. https://doi.org/10.1111/jth.12155
